Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Effect of Robot-assisted Gait Training on Gait Automaticity in Patients With Parkinson's Disease

Trial N/A Completed March 8, 2018

A Mobile Application for Telerehabilitation in Parkinson's Disease

Trial N/A Unknown March 8, 2018

Amyloid Beta and Cognition in Parkinson Disease

Trial N/A Completed March 7, 2018

Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease

Trial Phase 4 Unknown March 6, 2018

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

Trial N/A Completed Feb. 25, 2018

The Essential Tremor (ET) and Parkinson Disease (PD) Tremor Acute Stimulation Study

Trial N/A Withdrawn Feb. 22, 2018

Comparing the Effectiveness of Shotokan-Karate vs. Tai Chi on Balance and Quality of Life in Parkinson's Disease

Trial N/A Unknown Feb. 22, 2018

The Impact of Standard Medical Care (Dopamine) and Practice on Postural Motor Learning in Parkinson's Disease

Trial N/A Completed Feb. 21, 2018

Exogenous Effects of Standard Medical Care (Dopamine) on Motor Learning of an Upper Limb Task in Parkinson Disease

Trial N/A Completed Feb. 21, 2018

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

Trial Phase 2 Completed Feb. 19, 2018

Neural Signatures of Parkinson's Disease

Trial N/A Completed Feb. 19, 2018

Kinesia 360 Parkinson's Monitoring Study

Trial N/A Completed Feb. 18, 2018

Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles

Trial Phase 4 Completed Feb. 14, 2018

Arousal Response Tool for Neurological Disease

Trial N/A Unknown Feb. 7, 2018

Feasibility of Continuous Sleep Recording in Patients Undergoing Deep Brain Stimulation for Parkinson's Disease

Trial N/A Completed Feb. 6, 2018

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

Trial Phase 3 Completed Feb. 5, 2018

Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection

Trial N/A Unknown Feb. 4, 2018

DNS-7801 vs. Placebo in Parkinson's Disease

Trial Phase 2 Terminated Jan. 31, 2018

Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease

Trial N/A Terminated Jan. 31, 2018

Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease

Trial Phase 4 Unknown Jan. 29, 2018